A different kind of support for your weight loss.

Formoline® is a non-prescription tablet that binds to some of the fat in your food, so your body absorbs less of it.

You don’t need an injection or a prescription. It’s a simple daily routine that works alongside a calorie-controlled diet.

Not a medication. A different approach.

Weight loss medicines like Mounjaro® and Wegovy® work on appetite. They help you feel fuller and eat less. Formoline works differently. It doesn’t change your appetite at all. It acts in your digestive system and reduces how much fat from your meals your body takes in.

So it can suit people who want help with their weight but aren’t eligible for medication, or don’t want it.

Formoline® L112 EXTRA

About Formoline® L112 EXTRA

What is Formoline®?

Formoline is a non-prescription weight management product. It’s a fat-binding supplement, not an appetite suppressant. It’s designed to help with weight loss when you take it alongside a calorie-controlled diet.

The active ingredient in Formoline L112 is polyglucosamine, a patented fibre complex made from crustacean shells. It works in three steps:

  1. It binds fat. Polyglucosamine attaches to some of the fat in the food you’ve eaten.
  2. Less fat gets absorbed. Your digestive tract can’t absorb the bound fat as easily.
  3. It passes through. The fat-fibre complex moves through your digestive system and leaves your body in your stools.

 

The result: fewer calories from fat get absorbed.

Your goalDoseDaily total
Weight loss2 tablets twice daily4 tablets
Weight maintenance1 tablet twice daily2 tablets

 

Formoline can only bind fat that’s in your digestive system when you take it, so timing makes a real difference:

  • Take it with your two meals that contain the most fat
  • Take it towards the end of the meal if you can
  • Swallow the tablets whole with at least 250ml of water
  • Don’t chew or dissolve them
  • Drink at least 2 litres of fluid a day

Formoline L112 is for adults aged 18 and over who are overweight or obese, usually with a BMI of 25 or above. It isn’t a general slimming supplement for everyone. It’s designed to support weight loss alongside a calorie-controlled diet.

Formoline isn’t suitable if you:

  • Have a shellfish or crustacean allergy
  • Are pregnant or breastfeeding
  • Have chronic constipation or an intestinal obstruction
  • Take medicines that significantly slow down your gut

A 12-month randomised controlled trial compared Formoline L112 with a placebo. Both groups also followed a calorie-reduced diet and became more physically active.

After 12 monthsFormolinePlacebo
Average starting weight95.2kg95.5kg
Average weight loss12.1kg8.0kg
Percentage weight loss12.7%8.4%
Waist reduction13.3cm10.2cm

The trial only had 97 participants, so these results shouldn’t be taken as typical. Your own results will depend on your diet, your activity and how your body responds.

MEDICATION VS FORMOLINE

Which is right for you?

The right choice depends on your lifestyle, goals and personal circumstances. That’s why at Streamline, we offer a full wraparound service – combining expert clinical support, dedicated patient advisers and specialist dietary guidance — so you get the most out of your weight loss journey.

Wegovy (Pill)
Foundayo
Wegovy (Injection)
Mounjaro
Formoline (Supplement)
Format
Once-daily tablet
Once-daily tablet
Once-weekly injection (pen)
Once-weekly injection (pen)
Once or twice daily (supplement)
Availability
Available now
Available now
Available now
Available now
Available now
Starting dose (initiation)
1.5mg
0.8mg
0.25mg
2.5mg
750mg x 2 (4 tablets/day)
Maximum dose (maintenance)
25mg
17.2mg
7.2mg
15mg
750g x 1 (2 tablets/day)
Clinically proven
Yes
Yes
Yes
Yes
Yes
Average weight loss
13.6%³
11.1%⁴
20.7%²
20.9%¹
12.7%⁵
Fasting required
Yes
No
No
No
No
Storage requirements
Room temperature
Room temperature
Fridge (unopened)
Fridge (unopened)
Room temperature
Included with Streamline
Video consultation with a clinical specialist
Not applicable
Dedicated patient adviser support
Specialist dietitian support
Regular support resources
Exercise advice & support
Vitamin & minerals support

How it works with Streamline

From the treatment you choose to the support you receive along the way, our approach is built around expert clinical care and you as an individual.

Completed your online assessement
Tell us about your health, your goals and your weight loss journey through our simple online assessment.
1
Choose your plan
Choose between our programmes. Not sure which is right for you? Give our advisor team a call and we'll talk you through your options.
2
Speak to a clinician
If you choose a prescription medication, you'll be booked in with one of our clinicians, who will review your assessment and make sure your chosen treatment is clinically appropriate for you.
3
Delivered to your door
Once your treatment has been approved, our advisor team will arrange delivery for a day that works for you.
4
Support beyond your treatment
Your journey doesn't end when your medication arrives. You'll have access to ongoing support, useful resources and guidance to help you stay informed and on track.
5

COMMON QUESTIONS

Frequently asked questions

Do I need a prescription for Formoline?

No. Formoline is a non-prescription product, so you don’t need a clinical consultation to buy it. You still need to check that it’s suitable for you. See who shouldn’t take it above.

No. Mounjaro and Wegovy are prescription medicines that act on appetite. Formoline doesn’t affect your appetite. It binds some of the fat in your food so your body absorbs less of it.

No. Polyglucosamine is made from crustacean shells, so Formoline isn’t suitable for anyone with a shellfish or crustacean allergy.

With your two meals that have the most fat in them, ideally towards the end of the meal. Swallow the tablets whole with at least 250ml of water.

Yes. Formoline is designed to work alongside a calorie-controlled diet and more physical activity. It isn’t a replacement for either.

Polyglucosamine is a fibre, so drinking enough fluid helps it move through your digestive system. Aim for at least 2 litres a day.

Yes. The maintenance dose is 1 tablet twice a day, taken with your two highest-fat meals.

It varies from person to person. In a 12-month trial, people who took Formoline alongside diet and exercise lost an average of 12.1kg, compared with 8.0kg on placebo. The study was small, so treat these figures as a guide, not a promise.

Clinical results

Clinical trials have shown that weight loss treatments can lead to significant weight loss when combined with lifestyle support. Results vary depending on the treatment, dose and length of treatment.

  • Mounjaro (tirzepatide 15 mg): 20.9% average weight loss after 72 weeks¹
  • Wegovy injection (semaglutide 7.2 mg): 20.7% average weight loss at 72 weeks²
  • Wegovy tablets (oral semaglutide 25 mg): 13.6% average weight loss after 64 weeks³
  • Orforglipron: approximately 11% average weight loss after 72 weeks⁴
  • Formoline L112 (polyglucosamine): 12.7% average weight loss after 12 months, compared with 8.4% on placebo⁵

These figures are taken from separate clinical trials and should not be considered a direct comparison between treatments. Individual results can vary.

References

  1. Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide once weekly for the treatment of obesity. N Engl J Med. 2022;387(3):205-216. doi:10.1056/NEJMoa2206038.
  2. Wharton S, Freitas P, Hjelmesæth J, Kabisch M, Kandler K, Lingvay I, et al. Once-weekly semaglutide 7.2 mg in adults with obesity (STEP UP): a randomised, controlled, phase 3b trial. Lancet Diabetes Endocrinol. 2025;13(11):949-963. doi:10.1016/S2213-8587(25)00226-8.
  3. Wharton S, Lingvay I, Bogdanski P, et al. Oral semaglutide at a dose of 25 mg in adults with overweight or obesity. N Engl J Med. 2025;393(11):1077-1087. doi:10.1056/NEJMoa2500969.
  4. Wharton S, Aronne LJ, Stefanski A, et al. Orforglipron, an oral small-molecule GLP-1 receptor agonist for obesity treatment. N Engl J Med. 2025;393(18):1796-1806. doi:10.1056/NEJMoa2511774.
  5. Cornelli U, Belcaro G, Recchia M, D’Orazio N. Long-term treatment of overweight and obesity with polyglucosamine (PG L112): randomized study compared with placebo in subjects after caloric restriction. Curr Dev Nutr. 2017;1(10):e000919. doi:10.3945/cdn.117.000919.

The Only UK Weight Loss Company Owned by Leading Bariatric Experts

Join our Newsletter and get expert advice, real patient stories and the latest from our team – straight to your inbox.